Gilead Sciences Inc (NASDAQ:GILD) - Share price - Overview

Stock Report

Gilead Sciences Inc GILD

Last Price
$77.20

Day Change
-0.06|-0.08%

As of 17/07/2018
19:59:06 EDT | USD
Minimum 15 Minutes Delay.

Last Close77.26
Day Range76.93 - 77.76
Mkt Cap100.40Bil
52-Wk Range64.27 - 89.54
Yield %2.82
ISINUS3755581036
Volume4,424,705
P/E29.35
P/S4.12
P/CF9.06

Share Price

Financials
201520162017
More ...
Income Statement
Revenue32,639.0030,390.0026,107.00
Operating Income22,193.0017,633.0014,124.00
Net Income18,108.0013,501.004,628.00
Basic EPS12.3710.083.54
Avg. Diluted Shares Outstanding1,5211,3581,319
Balance Sheet
Current Assets24,763.0020,445.0031,823.00
Non Current Assets27,076.0036,532.0038,460.00
Total Assets51,839.0056,977.0070,283.00
Current Liabilities9,893.009,219.0011,635.00
Total Liabilities---
Total Equity18,534.0018,887.0020,442.00
Cash Flow
Operating Cash Flow20,329.0016,669.0011,898.00
Capital Expenditure-747.00-748.00-590.00
Free Cash Flow19,582.0015,921.0011,308.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Value

Fiscal Year Ends

December

Employees

10,000
Key Stats
More ...
Price/Earning TTM29.15
Price/Book4.88
Price/Sales TTM4.13
Rev Growth (3 year avg)1.60
EPS Growth (3 year avg)-
Operating Margin % TTM54.10
Net Margin % TTM17.73
ROE TTM23.53
Debt/Equity1.51
Dividends
PreviousLatest
More ...
Declared Date06/02/1802/05/18
Ex-Div15/03/1814/06/18
Paid29/03/1828/06/18
Amnt0.570.57
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.